Autopsy report · NCT01239355
MK2206 in Treating Patients With Advanced Liver Cancer That Did Not Respond to Previous Therapy
Cause of deathOther
“Early termination for discouraging results”
Life of this trial
- Registered 1 month before it started.
- Ran for about 2 years 2 months before it stopped.
- 15 participants enrolled.
- Results were posted on the registry 2 years 8 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- National Cancer Institute (NCI)
- Sponsor type
- US National Institutes of Health
- Conditions
- Adult Hepatocellular Carcinoma; Advanced Adult Hepatocellular Carcinoma; Localized Non-Resectable Adult Liver Carcinoma; Recurrent Adult Liver Carcinoma
- Interventions
- Akt Inhibitor MK2206; Laboratory Biomarker Analysis
- Participants
- 15
- Sites
- 22
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.